Portfolio (Quarterly)
Guide ↗
Knott David M Jr
· CIK 0001892770| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SNDX | Syndax Pharmaceutical, Inc. | Healthcare | 437,245.0 | $9.6M | 5.05% | +15K | +3.6% | $21.86 | -10.6% |
| 2 | TVTX | Travere Therapeutics, Inc. | Healthcare | 147,282.0 | $8.4M | 4.42% | +7K | +4.7% | $56.81 | +15.6% |
| 3 | BBIO | Bridgebio Pharma, Inc. | Healthcare | 92,850.0 | $6.9M | 3.66% | +3K | +3.2% | $74.48 | +2.8% |
| 4 | ALKS | Alkermes PLC | Healthcare | 121,759.0 | $6.4M | 3.37% | +2K | +1.5% | $52.40 | -9.5% |
| 5 | COGT | Cogent Biosciences Inc. | Healthcare | 111,081.0 | $4.3M | 2.27% | +7K | +6.8% | $38.70 | -10.4% |
| 6 | AGIO | Agios Pharmaceutical, Inc. | Healthcare | 95,058.0 | $3.5M | 1.86% | +2K | +2.1% | $37.11 | -10.2% |
| 7 | RLMD | Relmada Therapeutics, Inc. | Healthcare | 451,000.0 | $3.1M | 1.65% | +12K | +2.7% | $6.92 | -37.4% |
| 8 | HELP | Cybin Inc | Healthcare | 370,000.0 | $2.4M | 1.29% | +20K | +5.7% | $6.61 | +84.3% |
| 9 | MDGL | Madrigal Pharmaaceuticals, Inc. | Healthcare | 3,000.0 | $1.6M | 0.85% | +1K | +50.0% | $536.95 | -0.6% |
| 10 | ARDX | Ardelyx, Inc. | Healthcare | 263,168.0 | $1.3M | 0.71% | +56K | +27.1% | $5.10 | -25.3% |
| 11 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 38,069.0 | $1.3M | 0.67% | +5K | +15.1% | $33.39 | -23.3% |
| 12 | CGEM | Cullinan Therapeutics, Inc. | Healthcare | 69,182.0 | $1.3M | 0.67% | +45K | +185.9% | $18.21 | +19.2% |
| 13 | CNTB | Connect Biopharma Holdings Limited | Healthcare | 444,862.0 | $1.1M | 0.56% | +57K | +14.7% | $2.38 | -6.3% |
| 14 | — | Pelthos Therapeutics, Inc. | — | 22,073.0 | $624K | 0.33% | +1K | +4.8% | $28.26 | — |
| 15 | — | Verastem Inc. | — | 155,000.0 | $592K | 0.31% | +51K | +49.0% | $3.82 | — |
| 16 | — | Solid Bioscience Inc. | — | 56,208.0 | $562K | 0.30% | +9K | +19.2% | $9.99 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
86.1%
Financial Services
10.0%
Technology
2.2%
Energy
0.6%
Consumer Defensive
0.4%
Real Estate
0.3%
Consumer Cyclical
0.2%
Industrials
0.2%
Basic Materials
0.1%